Literature DB >> 17377865

Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy?

A Turna1, O Solak, A Kilicgun, M Metin, A Sayar, A Gürses.   

Abstract

BACKGROUND: The extent and the necessity of lymph node dissection has yet to be defined after resectional surgery for lung cancer. We aimed to analyze the lobe-specific extent of lymph node positivity in patients who underwent preoperative mediastinoscopy as a routine strategy.
METHODS: A total of 280 patients with non-small cell lung cancer with negative mediastinoscopy were operated on in our center between January 1997 and June 2003. Hilar and mediastinal lymphadenectomy was performed in every patient.
RESULTS: The most commonly involved lymph nodes were found to be paratracheal station lymph nodes (n = 83; 96.5 %) for right upper lobe tumors, subcarinal station lymph nodes (n = 52; 88.1 %) for right lower lobe carcinomas, aorticopulmonary lymph nodes (n = 62; 92.5 %) for left upper lobe and subcarinal station lymph nodes (n = 49; 96.0 %) for left lower lobe tumors. In the patients with right upper lobe, right lower lobe and left lower lobe tumors, the presence of a tumor at these stations was found to be an indicator for poor prognosis ( P = 0.033, P = 0.0038 and P = 0.0016, respectively). Patients with multiple station N2 disease did not survive beyond 3 years.
CONCLUSIONS: In patients who underwent routine mediastinoscopy, lobe-specific lymph node dissection could be recommended. Patients with multilevel N2 involvement did not seem to benefit from resectional surgery.

Entities:  

Mesh:

Year:  2007        PMID: 17377865     DOI: 10.1055/s-2006-924626

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  6 in total

Review 1.  Selective lymph node dissection in early-stage non-small cell lung cancer.

Authors:  Han Han; Haiquan Chen
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  Selective versus systematic lymph node dissection (other than sampling) for clinical N2-negative non-small cell lung cancer: a meta-analysis of observational studies.

Authors:  Han Han; Yue Zhao; Haiquan Chen
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 3.  [Research progress of lobe-specific lymphadenectomy on early stage lung cancer operation].

Authors:  Jian Chen; Yang Shen-Tu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-01

4.  Assessment of non-lobe-specific lymph node metastasis in clinical stage IA non-small cell lung cancer.

Authors:  Zhirong Zhang; Jinbai Miao; Qirui Chen; Yili Fu; Hui Li; Bin Hu
Journal:  Thorac Cancer       Date:  2019-06-17       Impact factor: 3.500

5.  Dosimetric evaluation of the feasibility of stereotactic body radiotherapy for primary lung cancer with lobe-specific selective elective nodal irradiation.

Authors:  Tetsuya Komatsu; Etsuo Kunieda; Tadashi Kitahara; Takeshi Akiba; Ryuta Nagao; Tsuyoshi Fukuzawa
Journal:  J Radiat Res       Date:  2015-11-12       Impact factor: 2.724

6.  [Retrospective study on lobe-specific lymph node dissection for patients with early-stage non-small cell lung cancer].

Authors:  Jian Chen; Feng Mao; Zhengbo Song; Yang Shen-Tu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.